Citadel Advisors - PROMETHEUS BIOSCIENCES INC ownership

PROMETHEUS BIOSCIENCES INC's ticker is RXDX and the CUSIP is 74349U108. A total of 149 filers reported holding PROMETHEUS BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 1.60 and the average weighting 1.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of PROMETHEUS BIOSCIENCES INC
ValueSharesWeighting
Q1 2023$20,288,417
-67.9%
189,046
-67.1%
0.01%
-66.7%
Q4 2022$63,220,960
+624.9%
574,736
+288.9%
0.02%
+650.0%
Q3 2022$8,721,000
-56.9%
147,800
-79.4%
0.00%
-60.0%
Q2 2022$20,251,000
+2086.9%
717,403
+2828.5%
0.01%
Q1 2022$926,000
-1.9%
24,497
-36.3%
0.00%
Q2 2021$944,000
-7.9%
38,438
-31.5%
0.00%
Q1 2021$1,025,00056,1380.00%
Other shareholders
PROMETHEUS BIOSCIENCES INC shareholders Q3 2022
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 1,848,024$73,071,00064.85%
CHI Advisors LLC 1,752,243$69,283,00023.00%
Cormorant Asset Management, LP 1,848,024$73,071,0004.35%
Waypoint Capital Advisors, LLC 152,665$6,036,0004.14%
Perceptive Advisors 6,345,570$250,904,0001.94%
RTW INVESTMENTS, LP 3,264,031$129,060,0001.88%
Eventide Asset Management 3,742,507$145,120,0001.85%
Octagon Capital Advisors LP 200,000$7,908,0001.54%
PLATINUM INVESTMENT MANAGEMENT LTD 521,529$20,621,0000.57%
Rock Springs Capital Management LP 618,407$24,452,0000.56%
View complete list of PROMETHEUS BIOSCIENCES INC shareholders